Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 55 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Bloom Syndrome 6382137 Cytidine 5'-diphosphate reductase and thymidine kinase activities in phytohemagglutinin-stimulated lymphocytes of normal subjects of various ages and patients with immunodeficiency. diagnostic usage
unassigned
3
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Breast Neoplasms 8137252 Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. ongoing research
therapeutic application
unassigned
3
3
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinogenesis 24261083 Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics. diagnostic usage
unassigned
1
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinoma 146339 [Control mechanisms of the ribonucleotide reduction in mammalian tissue (author's transl)] diagnostic usage
ongoing research
unassigned
1
2
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinoma 9307288 Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice. ongoing research
therapeutic application
unassigned
4
4
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinoma 24926347 Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis. diagnostic usage
ongoing research
unassigned
4
3
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinoma, Hepatocellular 3083874 [Changes in the lymphoid cells of DNA and purine nucleotide synthesis and sensitivity to glucocorticoids associated with impairment of differentiation and immune function during tumor growth in mice. Thymocytes] causal interaction
unassigned
2
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinoma, Hepatocellular 3498909 Some biochemical mechanisms underlying the impairment of T and B cell immunity in C3HA mice during hepatoma growth. causal interaction
diagnostic usage
unassigned
3
1
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinoma, Hepatocellular 3835819 Potentiation of antimetabolite action by dibromodulcitol in cell culture. causal interaction
unassigned
1
0
Show all pathways known for 1.17.4.1Display the word mapDisplay the reaction diagram Show all sequences 1.17.4.1Carcinoma, Hepatocellular 6722778 Origin of increased deoxycytidine excretion into urine of rats bearing Yoshida ascites sarcoma. ongoing research
unassigned
3
0
Results 1 - 10 of 55 > >>